Mariaelena Pierobon
George Mason University(US)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Pancreatic and Hepatic Oncology Research, PI3K/AKT/mTOR signaling in cancer, Advanced Biosensing Techniques and Applications, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients(2019)1,248 cited
- → Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer(2019)699 cited
- → Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer(2015)507 cited
- → Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis(2012)357 cited
- → Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression(2015)271 cited
- → Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer(2019)213 cited
- → A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process(2008)204 cited
- → Laser capture microdissection technology(2007)190 cited
- → Mechanism of Cell Adaptation(2011)178 cited
- → Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer(2019)168 cited